Cargando…

Microbiome profile and calprotectin levels as markers of risk of recurrent Clostridioides difficile infection

INTRODUCTION: Clostridioides difficile infection (CDI) is the main cause of nosocomial diarrhoea in developed countries. Recurrent CDI (R-CDI), which affects 20%-30% of patients and significantly increases hospital stay and associated costs, is a key challenge. The main objective of this study was t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vázquez-Cuesta, Silvia, Lozano García, Nuria, Fernández, Ana I., Olmedo, María, Kestler, Martha, Alcalá, Luis, Marín, Mercedes, Bermejo, Javier, Díaz, Francisco Fernández-Avilés, Muñoz, Patricia, Bouza, Emilio, Reigadas, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534046/ https://www.ncbi.nlm.nih.gov/pubmed/37780848 http://dx.doi.org/10.3389/fcimb.2023.1237500

Ejemplares similares

Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients
por: Vázquez-Cuesta, Silvia, et al.
Publicado: (2023)

Clostridioides difficile infection epidemiology and clinical characteristics in COVID-19 pandemic
por: Vázquez-Cuesta, Silvia, et al.
Publicado: (2022)

Clinical impact of a Clostridioides (Clostridium) difficile bedside infectious disease stewardship intervention
por: Olmedo, María, et al.
Publicado: (2020)

Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
por: de la Villa, Sofía, et al.
Publicado: (2023)

Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results
por: Reigadas, Elena, et al.
Publicado: (2018)

Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridioides difficile infection
por: Yu, Si, et al.
Publicado: (2023)

2’-Fucosyllactose inhibits proliferation of Clostridioides difficile ATCC 43599 in the CDi-screen, an in vitro model simulating Clostridioides difficile infection
por: Wiese, Maria, et al.
Publicado: (2022)

Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience
por: Olmedo, María, et al.
Publicado: (2022)

Antibacterial Activity of Bifidobacterium breve Against Clostridioides difficile
por: Yang, Jingpeng, et al.
Publicado: (2019)

Antibiotic Resistance and Biofilm Production Capacity in Clostridioides difficile
por: Rahmoun, Layan Abu, et al.
Publicado: (2021)

An Atypical Case of Monomicrobial Clostridioides difficile Septicemia With No Gastrointestinal Manifestations
por: Wang, Liqian, et al.
Publicado: (2022)

Systematic review of guidelines for the diagnosis and treatment of Clostridioides difficile infection
por: Gu, Ting, et al.
Publicado: (2022)

Gut Microbiota Diversity of Preterm Neonates Is Associated With Clostridioides Difficile Colonization
por: Couturier, Jeanne, et al.
Publicado: (2022)

The impact of dietary fibers on Clostridioides difficile infection in a mouse model
por: Wu, Zhengjie, et al.
Publicado: (2022)

Usefulness of Fecal Calprotectin in the Management of Patients with Toxigenic Clostridioides difficile
por: Suarez-Carantoña, Cecilia, et al.
Publicado: (2021)

Transition From PCR-Ribotyping to Whole Genome Sequencing Based Typing of Clostridioides difficile
por: Seth-Smith, Helena M. B., et al.
Publicado: (2021)

High Prevalence of Multidrug-Resistant Clostridioides difficile Following Extensive Use of Antimicrobials in Hospitalized Patients in Kenya
por: Mutai, Winnie C., et al.
Publicado: (2021)

Application of a core genome sequence typing (cgMLST) pipeline for surveillance of Clostridioides difficile in China
por: Wang, Yuan Yuan, et al.
Publicado: (2023)

Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by Clostridioides difficile infection
por: Kulecka, Maria, et al.
Publicado: (2023)

High Dose Intramuscular Vitamin D3 Supplementation Impacts the Gut Microbiota of Patients With Clostridioides Difficile Infection
por: Lee, Sang Hoon, et al.
Publicado: (2022)

S100B Inhibition Attenuates Intestinal Damage and Diarrhea Severity During Clostridioides difficile Infection by Modulating Inflammatory Response
por: Costa, Deiziane V. S., et al.
Publicado: (2021)

Production of p-cresol by Decarboxylation of p-HPA by All Five Lineages of Clostridioides difficile Provides a Growth Advantage
por: Harrison, Mark A., et al.
Publicado: (2021)

Trehalose-Induced Remodelling of the Human Microbiota Affects Clostridioides difficile Infection Outcome in an In Vitro Colonic Model: A Pilot Study
por: Buckley, Anthony M., et al.
Publicado: (2021)

Comparative biofilm-forming ability between Clostridioides difficile strains isolated in Latin America and the epidemic NAP1/027 strain
por: Morais, Maria Luana Gaudencio dos Santos, et al.
Publicado: (2022)

The value of fecal calprotectin in Clostridioides difficile infection: A systematic review
por: Wen, Bao-Jiang, et al.
Publicado: (2022)

Low Density Lipoprotein Receptor-Related Protein-1 (LRP1) Is Involved in the Uptake of Clostridioides difficile Toxin A and Serves as an Internalizing Receptor
por: Schöttelndreier, Dennis, et al.
Publicado: (2020)

Disordered Intestinal Microbial Communities During Clostridioides difficile Colonization and Subsequent Infection of Hepatic Cirrhosis Patients in a Tertiary Care Hospital in China
por: Chen, Yunbo, et al.
Publicado: (2022)

Is it reasonable to perform Fecal Microbiota Transplantation for recurrent Clostridium difficile Infection in patients with liver cirrhosis?
por: Olmedo, Maria, et al.
Publicado: (2019)

The Immune Protein Calprotectin Impacts Clostridioides difficile Metabolism through Zinc Limitation
por: Lopez, Christopher A., et al.
Publicado: (2019)

Calprotectin as a diagnostic marker for sepsis: A meta-analysis
por: Gao, Rong-Yue, et al.
Publicado: (2022)

Leptin Receptor q223r Polymorphism Influences Clostridioides difficile Infection-Induced Neutrophil CXCR2 Expression in an Interleukin-1β Dependent Manner
por: Horrigan, Olivia, et al.
Publicado: (2021)

Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates
por: Pensinger, Daniel A., et al.
Publicado: (2023)

Successional Dynamics in the Gut Microbiome Determine the Success of Clostridium difficile Infection in Adult Pig Models
por: Jurburg, Stephanie D., et al.
Publicado: (2019)

The role of the gut microbiome in colonization resistance and recurrent Clostridioides difficile infection
por: Seekatz, Anna Maria, et al.
Publicado: (2022)

Identifying Anaerobic Bacteria Using MALDI-TOF Mass Spectrometry: A Four-Year Experience
por: Alcalá, Luis, et al.
Publicado: (2021)

Efficacy of lyophilised bacteria-rich faecal sediment and supernatant with reduced bacterial count for treating patients with Clostridioides difficile Infection – A novel method for capsule faecal microbiota transfer
por: Varga, Adorján, et al.
Publicado: (2023)

Risk factors for colonization with multidrug-resistant Gram-negative bacteria and Clostridioides difficile in Long Term Care Facilities (LTCFs) residents: the evidence from 27 facilities in a high endemic setting
por: Azzini, Anna Maria, et al.
Publicado: (2023)

The Innate Immune Protein Calprotectin Interacts With and Encases Biofilm Communities of Pseudomonas aeruginosa and Staphylococcus aureus
por: Baishya, Jiwasmika, et al.
Publicado: (2022)

Gut microbiome and Clostridioides difficile infection: a closer look at the microscopic interface
por: Sehgal, Kanika, et al.
Publicado: (2021)

Development and validation of a simple and robust model to predict 30-day mortality in patients with Clostridioides difficile-associated enterocolitis
por: Katzer, Katrin Claudia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0ufel82mvfjdco36d0lgq14iop